Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04467840
Brief Title: Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

First Submitted : July 9, 2020
First Submitted that Met QC Criteria : July 9, 2020
First Posted : July 13, 2020

Last Update Submitted that Met QC Criteria : July 19, 2021
Last Update Posted : July 20, 2021